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Background: When using Illumina high throughput short read data, sometimes the genotype inferred from the
positive strand and negative strand are significantly different, with one homozygous and the other heterozygous.
This phenomenon is known as strand bias. In this study, we used Illumina short-read sequencing data to evaluate
the effect of strand bias on genotyping quality, and to explore the possible causes of strand bias.
Result: We collected 22 breast cancer samples from 22 patients and sequenced their exome using the Illumina
GAIIx machine. By comparing the consistency between the genotypes inferred from this sequencing data with the
genotypes inferred from SNP chip data, we found that, when using sequencing data, SNPs with extreme strand bias
did not have significantly lower consistency rates compared to SNPs with low or no strand bias. However, this
result may be limited by the small subset of SNPs present in both the exome sequencing and the SNP chip data.
We further compared the transition and transversion ratio and the number of novel non-synonymous SNPs
between the SNPs with low or no strand bias and those with extreme strand bias, and found that SNPs with low or
no strand bias have better overall quality. We also discovered that the strand bias occurs randomly at genomic
positions across these samples, and observed no consistent pattern of strand bias location across samples. By
comparing results from two different aligners, BWA and Bowtie, we found very consistent strand bias patterns. Thus
strand bias is unlikely to be caused by alignment artifacts. We successfully replicated our results using two
additional independent datasets with different capturing methods and Illumina sequencers.
Conclusion: Extreme strand bias indicates a potential high false-positive rate for SNPs.
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Over the last few years, high throughput sequencing
technology has matured technically while becoming
more affordable and is now the preferred approach for
the discovery of novel mutations and differentially
expressed genes. Even though the data produced by high
throughput sequencing are richer and more informative
than data generated from other traditional high through-
put genomic technologies, the post analysis phase of
next generation sequencing data presents numerous
novel difficulties. A primary challenge associated with
sequencing data analysis is the accurate detection of sin-
gle nucleotide polymorphism (SNP)/mutation. Many
issues can affect SNP/mutation detection accuracy. In* Correspondence: yu.shyr@Vanderbilt. Edu
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reproduction in any medium, provided the orthis study, we focused on strand bias, one of the many
issues concerned with SNP/mutation detection. Strand
bias occurs when the genotype inferred from informa-
tion presented by the forward strand and the reverse
strand disagrees. For example, at a given position in the
genome, the reads mapped to the forward strand sup-
port a heterozygous genotype, while the reads mapped
to the reverse strand support a homozygous genotype
(examples are given in Table 1). Due to the lack of trans-
parency in the sequencing analysis pipeline and because
most analysis tools will only report the final variant
results, the issue of strand bias is not widely known. No
standard analysis programs report nucleotide counts
separately by the forward and reverse strands. However,
strand bias actively concerns some researchers and
developers of sequencing analysis and they have devoted
some effort to measure strand bias. For example, the
widely used Genome Analysis Tool Kit (GATK) [1],. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Strand bias examples from real data
Chr Pos Depth a1 b2 c3 d4 Forward Strand Genotype Reverse Strand Genotype
6 32975014 21 5 5 10 1 Heterzygous Homozygous
1 81967962 38 20 11 7 0 Heterzygous Homozygous
12 10215654 31 15 9 7 0 Heterzygous Homozygous
1. Forward strand reference allele.
2. Forward strand non reference allele.
3. Reverse strand reference allele.
4. Reverse strand non reference allele.
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bias score for each SNP identified. Another well-
known sequencing analysis program, Samtools [2], also
computes a strand bias score based on Fisher's exact
test. The common practice has been to either ignore
strand bias due to lack of knowledge or to use strand
bias as a filter to reduce false-positive SNPs, thus re-
ducing the overall call rate. However, to what extent
strand bias may adversely affect genotyping quality in
sequencing data has not been studied thoroughly.
Thus, we designed this study to examine the effect of
strand bias on genotyping quality and tried to identify
the causes of strand bias.
Unbalanced strand mapping is a phenomenon when
the number of reads mapped to forward and reverse
strands are significantly different. In extreme cases, all
reads are mapped to one strand, leaving the other
strand completely uncovered. Unbalanced strand map-
ping is also considered to be a type of strand bias.
Fundamentally, however, it is a different problem from
strand bias in the calls. In a previous study [3], we
have shown that unbalanced strand mapping is an
artifact of the exome capturing mechanism and does
not affect the quality of the genotyping. Thus, in the
current study we focused only on strand bias related
to the genotype call difference between the forward
and reverse strands.
Methods
Data description and processing
We randomly selected whole exome sequencing data for
22 breast cancer patients recruited to the Shanghai
Breast Cancer Study (SBCS). The SBCS is a large,
population-based case–control study of women in urban
Shanghai, the details of which have been previously
described [4,5]. All patients had very early-onset (22–
32 years old) breast cancer or early-onset (38–41 years
old) plus a first-degree family history of breast cancer.
Approval of the study was granted by the relevant insti-
tutional review boards in both China and the United
States. Genomic DNA from buffy coat samples was
extracted using QIAmp DNA kit (Qiagen, Valencia, CA)
following the manufacturer’s protocol. All samples have
been genotyped using the Affymetrix 6.0 array in aprevious genome wide association study [4]. All patients
in this study signed written informed consent. The
approvals of the study were given by the institutional re-
view board of Shanghai Cancer Institute and Vanderbilt
University.
Sequencing was performed at the Genome Service Lab
at Hudson Alpha Institute. Data were 72-base paired-
end reads generated from Illumina GA IIx machines.
Each sample was run on a single lane of a flowcell. DNA
enrichment was done using the Agilent SureSelect
Human All Exon kit v1, which was designed to target
165,637 genomic regions (37.8 million bases; 71.6% in-
side exons; average length 228 bp).
We shifted the Illumina base quality scores (Phred+64)
to the Sanger scale (Phred+33) [6] and performed an
initial alignment to the National Center for Biotechnol-
ogy Information human reference genome HG19 using
the program Burrows-Wheeler Aligner (BWA) [7]. We
then marked duplicates with Picard and carried out re-
gional realignment and quality score recalibration using
the Genome Analysis Toolkit (GATK) [1]. For variant
calling, we only used reads with a mapping quality score
(MAPQ) ≥20 (i.e., ≤1% probability of being wrong) and
bases with base quality score (BQ) ≥20. We used
GATK's Unified Genotyper to call SNPs simultaneously
on all samples.
The same 22 samples were genotyped using the Affy-
metrix Genome-Wide Human SNP Array 6.0 which fea-
tures 1.8 million genetic markers, including more than
906,600 SNPs. Approximately one-third of the SNPs on
the Affymetrix Genome-Wide Human SNP Array 6.0
reside in the exome regions covered by the Agilent Sure-
Select Human All Exon kit v2.
Two additional independent datasets were used to val-
idate our findings. The first additional data set contains
six samples, randomly selected from the 1000 Genomes
Project [8], that were sequenced on the Illumina GAII
with capturing performed with an array based method.
The second additional dataset contains six samples
sequenced on the Illumina HiSeq 2000 sequencer, with
capturing performed with the Illumina TruSeq capture
kit. The variety of capture methods and sequencers used
to collect those data provided more robustness for our
study.
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Sequencing data at a single position in the genome can
be represented by a 2 by 2 table c
a
d
b where a, c represent
the forward and reverse strands allele counts of the
major allele, and b, d represent the forward and reverse
strands’ allele counts for the minor allele. Occasionally,
reads can align to a third allele at a given genomic pos-
ition. Such third alleles are likely due to sequencing or
alignment errors. Thus we discarded the third allele
from the analysis in the rare cases where it was
observed. Several strand bias examples from real data
can be viewed in Table 1. Based on the 2 by 2 table, we
can calculate three scores to measure strand bias:




calculation of SB has been used previously in a
mitochondria heteroplasmy study [9]
2. GATK-SB: GATK-SB is the strand bias score










3. Fisher Score: The Fisher Score is derived from Fisher
p-value and is calculated in the standard way using
the 2 by 2 table. To ensure directional consistency
with the SB and GATK-SB scores, the Fisher Score is
defined as 1 minus the p-value.
Both SB and GATK-SB scores have ranges from 0 to
infinity, while the Fisher score has a range from 0 to 1.
For all 3 scores as we have defined them, lower values
mean less strand bias and higher scores mean a more se-
vere strand bias.
Strand bias and genotype quality
Genotype consistency between sequencing calls and
genotyping chip calls has been used as a quality control
for sequencing data [3]. For example, GATK has a
built-in tool that uses genotyping chip consistency as a
SNP quality recalibration criterion. We performed a
consistency analysis between the genotype inferred from
the exome sequencing data and the genotype inferred
from the SNP chip data. When inferring genotypes using
sequencing data, all the genomic positions can be
divided into two major categories: homozygous and het-
erozygous. Strand bias has no effect on the quality of
homozygous genotype calls, because regardless of how
severe the strand bias might be, it lacks sufficient influ-
ence to force the genotype caller to make a false hetero-
zygous inference. Thus, in our analysis, we only
considered heterozygous SNPs called by GATK's Unified
Genotyper. The consistency is defined as the number of
heterozygous SNPs with a consistent genotype between
the exome sequencing data and the SNP chip data
divided by all overlapped (with exome sequencing) het-
erozygous SNPs in the SNP chip data.The SNPs present in both the Affymetrix 6.0 SNP
Chip and the exome sequencing data are only a small
percentage of the SNPs identified by exome sequencing.
Thus, we computed other genotype quality control para-
meters such as the transition/transversion (Ti/Tv) ratio,
and the number of novel non-synonymous SNPs. The
Ti/Tv ratio is around 3.0 for SNPs inside exons and
about 2.0 elsewhere [10]; it also differs between syn-
onymous and non-synonymous SNPs [11]. Because the
target regions of exome capture kits often cover more
than just exons, the Ti/Tv ratio for SNPs inside these
target regions is expected to lie between 2.0 and 3.0 with
the value depending on the fraction of exons inside tar-
get regions. We also compared the Ti/Tv ratios between
SNPs with low or no strand bias and SNPs with extreme
strand bias in novel SNPs and the SNPs reported in
dbSNP. Furthermore, the number of novel non-
synonymous SNPs can also be a very good indicator of
the false positive rate. A study [12] have shown that only
200–300 novel nonsynonymous SNPs should be identi-
fied per person by exome sequencing; a higher number
would likely indicate a higher false-positive rate.
Cause of strand bias
To identify the cause of strand bias, we want to initially
determine if the strand bias occurs systematically across
subjects. Thus, we examined the strand bias score
consistency between samples. For the 22 breast cancer
samples, there are total of 231 possible pairs. For each
pair, we selected positions in the top 20 percent of
strand bias scores from one subject in the pair, and com-
puted the Pearson correlation coefficient using the
strand bias scores at the selected positions between the
two samples in the pair. By only selecting the positions
with high strand bias scores in one subject in the pair,
we can effectively capture the scenario where two sub-
jects have significantly different strand bias scores at the
same positions. Box plots were used to show the distri-
bution of the correlations across the 231 pairs.
We also hypothesized that post analysis procedures
may also contribute to the cause of strand bias. After
initial alignment, several popular enrichment steps are
often used to reduce the genotyping false-positive rate.
Such steps include local realignment, base quality score
recalibration, base alignment quality recalibration
(BAQ), and removal of duplicate reads. Based on the
popularity of these steps, we examined the strand bias
score using four different processing pipelines: (1) initial
alignment (without performing any enrichment steps,
denoted as initial alignment); (2) realignment, recalibra-
tion and removal of duplicates (denoted as realignment);
(3) base alignment quality recalibration (denoted as
BAQ); (4) local realignment plus BAQ (denoted as rea-
lignBAQ). We computed the Pearson's correlation
Figure 1 Consistency rates with SNP chip data using 3 strand bias scores and 4 processing pipelines.
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scores between each processing pipeline. Finally, we rea-
ligned our data using a second aligner Bowtie, and com-
pared the strand bias scores computed from alignment
bam files between Bowtie and BWA.
Results
SNP Chip genotyping quality
The 22 breast cancer patient samples sequenced with
the Agilent SureSelect capture kit were taken from 2776
patients who were genotyped using the Affymetrix SNP
6.0 array in a genome-wide association study; detailed
genotyping methods and stringent QC criteria were
described in Zheng et al. [4]. The original scan included
three quality control samples in each 96-well plate, and
the SNP calls showed a very high concordance rate
(mean 99.9%; median 100%) for the quality control sam-
ples. In addition, 742 SNPs were genotyped using alter-
native genotyping platforms for a subset of subjects;
these SNPs also had a high concordance rate with geno-
types obtained from the SNP chip (mean 99.1%; median
99.8%). The SNP chip call rate for the 22 samples inves-
tigated here ranged from 97.83% to 97.84%.
Sequencing data quality
Our sequencing data has high quality. Table S1 contains
detailed summaries of the samples studied. For the 22
samples sequenced with the Agilent SureSelect captureTable 2 SNP quality by MAF and subset1
MAF 0–0.1 MAF 0.1-0.2 M
All Seq SNPs 70825/2.35 8454/1.93 26
Overlapped SNPs 4123/2.99 2781/2.8 27
Seq SNPs - Chip SNPs 66702/2.31 25673/1.86 23
dbSNP SNPs in Seq 53520/2.43 23458/2.21 21
dbSNP SNPs not on Chip 49397/2.39 20677/2.15 18
1. Each cell is represented in the format of number of SNPs/TiTv ratio.kit, we obtained an average of 68.9 (range 44.6-78.2) mil-
lion reads per subject, with 45x median depth for the
SureSelect target regions. On average, 91.4% (88.4-
93.8%) of the reads were aligned to the human reference
genome, and 86.2% (82.1-89.3%) had an insert size ≤
500. The six samples sequenced with the Illumina True-
Seq capture kit had an average of 93.8 (range 91.3-98.0)
million reads and achieved 48x median depth for the
TrueSeq target regions. On average, 95.1% (94.9-95.6%)
of the reads had insert size ≤ 500. The six samples
sequenced by the 1000 Genomes Project had an average
of 67.9 (range 47.5-83.7) million reads and achieved 59x
median depth for their target regions. On average, 89.7%
(72.1-99.1%) of the reads had insert size ≤ 500.
Strand bias and genotyping quality
To evaluate the effect of strand bias on genotype quality,
we plotted the strand bias scores quantile (5% each)
against the genotype consistency between genotypes in-
ferred from exome sequencing data and SNP chip data
(Figure 1). The strand bias scores are more accurate if
high numbers of reads are observed on both strands;
thus, we used a forward depth ≥ 10 and a reverse depth
≥ 10 as a filter. We observed that, for both the SB and
Fisher scores, a minor drop in the heterozygous geno-
type consistency rate (< 1%) was detected as strand bias
scores increased from the 80 percentile to the 100 per-
centile. We hypothesized that Affymetrix’s SNP selectionAF 0.2-0.3 MAF 0.3-0.4 MAF0.4-0.5 Overall
074/1.94 19092/1.96 30532/1.85 174977/2.08
99/2.73 2160/2.53 2504/2.69 14367/2.78
275/1.87 16932/1.9 28028/1.79 160610/2.03
798/2.23 16359/2.2 26152/2.05 141287/2.26
999/2.17 14199/2.16 23638/2.00 126920/2.21
Figure 2 Genotyping quality control through Ti/Tv ratio.
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Table 3 SB and GATK-SB difference
Chr Pos a1 b2 c3 d4 SB GATK-SB Fisher Genotype GATK Genotype GWAS
7 43917013 11 2 20 0 2.54 0.16 0.85 AG AA
14 95923670 16 2 10 0 1.56 0.12 0.48 CT TT
19 57088850 8 2 16 0 2.6 0.21 0.86 AC AA
1. Forward strand reference allele.
2. Forward strand non reference allele.
3. Reverse strand reference allele.
4. Reverse strand non reference allele.
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exome sequencing technology. Thus, the overlapping
subset of SNPs has better quality than the rest of the
SNPs and the consistency rate for this subset of SNPs
might not represent the overall quality of SNPs identi-
fied by exome sequencing. To test this hypothesis, we
compared the SNPs on the Affymetrix 6.0 chip with theFigure 3 Strand bias consistency across subjects.rest of the SNPs identified by the exome sequencing,
grouped by minor allele frequency (MAF) (Table 2). The
dbSNP and exome sequencing overlap subset had a Ti/
Tv ratio of 2.26, which is higher than the average Ti/Tv
ratio of 2.08 for all sequenced SNPs. This is consistent
with our previous finding [3] that showed a higher qual-
ity for dbSNP SNPs than for novel SNPs. This can be
Figure 4 Strand bias correlations between Bowtie and BWA.
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in novel SNPs compared to the previously reported
SNPs. The most interesting observation was that the
overlapping SNPs between the exome sequencing and
the genotyping chip (also a subset of dbSNP SNPs) had
a higher Ti/Tv ratio than the rest of the dbSNP SNPs
(2.78 vs 2.21). This evidence supports our hypothesis
that the Affymetrix 6.0 genotyping chip’s SNPs are more
easily sequenced than the full set of SNPs reported by
the exome sequencing.
Furthermore, we performed quality control tests on
SNPs with low or no strand bias (bottom 10%) and SNPs
with high bias (top 10%) (Figure 2). For the SB and
Fisher scores, we observed an overall better quality for
SNPs with low or no strand bias than for SNPs with ex-
treme bias. For example, using the SB score, we identi-
fied, on average, a Ti/Tv ratio of 2.47 for SNPs with low
or no strand bias, while the Ti/Tv ratio for SNPs with
extreme bias was 1.25. For novel SNPs, the Ti/Tv ratio
was 1.51 and 0.98 for SNPs with low and high strand
bias, respectively. However, using the SB-GATK score,
we observed some misleading results. For example, using
the SB-GATK score, we identified an average Ti/Tv ratio
of 1.3 for SNPs with low or no strand bias, while the
average Ti/Tv ratio for SNPs with extreme bias was 2.2.
For novel SNPs, the average Ti/Tv ratio was 1.2 and 1.1
for SNPs with low and high strand bias, respectively,
according to GATK-SB score. For the number of non-
synonymous SNPs, similar contradictory results between
the SB, the Fisher scores and the GATK-SB score were
observed. SNPs with low or no strand bias contained areasonably low number of novel non-synonymous SNPs,
and SNPs with extreme bias contained an unreasonably
higher number of novel non-synonymous SNPs accord-
ing to the SB and Fisher scores while the GATK-SB
score showed the opposite results. Upon further investi-
gation, we found that for certain situations, GATK-SB
can produce a different score from the SB and Fisher
scores. Three examples are given in Table 3. In all three
examples, the non-reference allele has low counts on
both strands. In case where b << a and d << c, the defin-





choices are small. In contrast, the SB measure goes to
infinity as b << a and d << c, as long as ba≠
d
c . The SB
and Fisher scores indicated quite strong strand bias at
these three given genome positions while GATK-SB indi-
cated a low strand bias for those positions. Furthermore,
GATK’s Unified Genotyper made different genotype calls
from the SNP chip data for all three genome positions.
It is very likely that GATK’s Unified Genotyper made the
wrong genotype calls on these positions. Thus we see an
artifact where the SNPs with higher strand bias actually
have higher Ti/Tv ratios than SNPs with low or no
strand bias for the GATK-SB score. This result shows
that the GATK-SB score is capturing a different group of
SNPs than the SB and Fisher scores in the situation
described in Table 2. The complete results of genotype
quality control can be found in Table S2.
Causes of strand bias
To study strand bias in greater detail we explored its re-
peatability across samples. For the 22 breast cancer
Figure 5 Correlation of strand bias scores between different processing pipelines.
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the Pearson's correlation coefficient between their strand
bias scores. We plotted box plots of Pearson's correl-
ation coefficients of all three strand bias scores for all
possible 231 pairs of subjects (Figure 3). Unlike unba-
lanced strands that we have previously shown to occur
consistently across subjects due to capture artifacts [3],
no consistent pattern was detectable for strand bias. The
median correlation coefficients of all three strand bias
scores were near zero, suggesting that strand bias does
not occur consistently at the same genomic sites across
subjects.To determine the role of the alignment method in
generating strand bias, we aligned our samples using
an additional aligner: Bowtie [13]. Then we computed
the Pearson's correlation coefficients of all three allele
frequency scores between the BWA and Bowtie align-
ments (Figure 4). High correlations (r >0.85) were
observed for all three strand bias scores between BWA
and Bowtie alignments. This result suggests that strand
bias is likely not an artifact of alignment, since high
levels of strand bias at the same genomic sites were
reproduced using these different alignment methods.
However, we cannot completely rule out the possibility
Figure 6 Scatter plot of strand bias scores between different processing pipelines.
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caused similar strand bias.
We calculated Pearson's correlation coefficients for all
three strand bias scores among the four processing pipe-
lines that we have described in the Methods section.
High correlations (median r > 0.90) were observed
between the strand bias scores computed from the dif-
ferent pipelines, except for the RealignBAQ pipeline
(median r < 0.70) (Figure 5). These results suggest that
the post analysis procedures such as local realignment,
recalibration, and BAQ did not contribute to the causes
of strand bias. However, the pipeline using local realign-
ment plus BAQ had relatively low strand bias correlation
with other processing pipelines. From the scatter plot
(Figure 6), we can also see that realignBAQ introduced
more SNPs with higher strand bias. The phenomenon
observed for realignBAQ is primarily due to the redun-
dancy between local realignment and BAQ. Both the
local realignment and BAQ procedures are designed to
lower the SNP false-positive rate, one by adjusting the
alignment and the other by adjusting the base quality
score around indel regions. Applying both in the same
pipeline (as we did in the RealignBAQ pipeline) pro-
duced an adverse effect causing larger strand biases.All analyses described were repeated using two add-
itional independent datasets. Similar findings were
observed without exception. The results for the add-
itional datasets can be viewed in the supplementary
material.
Discussion
Due to its vast popularity and easily accessible data, we
focused our study on exome sequencing data from the
Illumina sequencing platform. We did not evaluate
strand bias on data generated by other sequencing plat-
forms, such as 454 Life Science and Applied Biosystems.
We speculate that the same phenomenon exists for the
Applied Biosystems sequencing platform, because its
technology can generate a similar depth of data com-
pared to Illumina’s platform. However, it would be hard
to observe or study strand bias on the 454 Life Science’s
sequencing platform, due to its limited depth.
An interesting finding from this study is that sequen-
cing data and genotyping chip consistency might not
represent the whole picture of sequencing data quality,
as we previously thought. The overlapping subset of
SNPs is small compared to all SNPs identified through
exome sequencing. Also, all SNPs on the standard
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portion is not a random sample from all SNPs identified
by exome sequencing. The exact SNP selection criteria
for the Affymetrix 6.0 SNP chip are unknown to us. We
speculate that criteria such as GC content, proximity to
other SNPs and the ease of enzyme ligation should be
considered; these factors also impact the sequencing
quality. We observed a better quality for genotyping chip
SNPs in sequencing, raising concerns about the effect-
iveness of using genotyping chip consistency rate as a
quality control for SNPs identified by sequencing. We
believe that the genotyping chip consistency can still be
used as a quality control; however, the use of other qual-
ity control parameters, such as the Ti/Tv ratio and the
number of novel non-synonymous SNPs in conjunction,
is essential for obtaining an accurate description of the
SNPs identified by sequencing.
Conclusions
We found that strand bias does not consistently occur at
the same genomic sites across different samples. By
comparing strand bias using different post-analysis pipe-
lines, we found some evidence to support the hypothesis
that post-analysis procedures can cause strand bias, es-
pecially for the processing pipeline that applies both
local realignment and BAQ. Such processing pipelines
can introduce more SNPs with higher strand bias, which
in turn results in more false-positive SNPs. Use of local
realignment and BAQ in the same processing pipeline
should be avoided. The correlation of allele frequency
scores between BWA and Bowtie were very high, indi-
cating that strand bias is not likely due (although not
completely ruled out) to the artifacts of alignment, but is
more likely an artifact or due to errors from the library
preparation or sequencing. A portion of the strand bias
can also be caused by sampling variation during the
sequencing.
For the three strand bias scores we have studied, SB,
GATK-SB, and Fisher scores, we evaluated their effect-
iveness in capturing true false-positive SNPs. Based on
our results, the Fisher and SB scores can capture true
false-positive SNPs better than the GATK-SB score. By
comparing exome sequencing data with SNP chip data,
the SB and Fisher scores indicated slight drops in het-
erozygous consistency when strand bias scores were over
the 80th percentile. However, the magnitude of the
consistency rate drop is minor. From the other genotype
quality control parameters, such as Ti/Tv ratio and num-
ber of novel non-synonymous SNPs, we observed an
overall better quality for SNPs with low or no strand
bias than for SNPs with extreme strand bias. Based on
our findings, strand bias can negatively affect the geno-
typing quality of sequencing data. We recommendcaution when applying strand bias as a filter. Only SNPs
with extreme strand bias should be regarded as false-
positive candidates. We considered SNPs with strand
bias score in the top 10% as extreme. VarScan [14], a
variant calling tool also uses the top 10% rather than a
fixed numerical score as a strand bias filter. Indiscrimi-
nant use of strand bias as a filter will result in a large
loss of true positive SNPs.
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